Abiraterone mesylate is a pharmaceutical compound primarily used in the treatment of prostate cancer. It is a prodrug of abiraterone, which inhibits the enzyme CYP17A1, crucial for androgen synthesis. This inhibition leads to a decrease in testosterone production, thereby slowing the growth of androgen-dependent tumors. The mesylate salt form enhances the solubility and bioavailability of the drug, facilitating its absorption in the body. Abiraterone mesylate is typically administered orally and is often used in combination with corticosteroids to mitigate potential side effects associated with hormone deprivation. The compound is characterized by its specific molecular structure, which includes a steroid backbone modified to enhance its pharmacological properties. Safety and efficacy profiles have been established through clinical trials, and it is generally well-tolerated, although some patients may experience side effects such as hypertension, hypokalemia, and liver function abnormalities. As with any medication, it is essential to use abiraterone mesylate under the guidance of a healthcare professional.

Abiraterone mesylate

1382475-35-5: Abiraterone mesylate is a pharmaceutical compound primarily used in the treatment of prostate cancer. It is a prodrug of abiraterone, which inhibits the enzyme CYP17A1, crucial for androgen synthesis. This inhibition leads to a decrease in testosterone production, thereby slowing the growth of androgen-dependent tumors. The mesylate salt form enhances the solubility and bioavailability of the drug, facilitating its absorption in the body. Abiraterone mesylate is typically administered orally and is often used in combination with corticosteroids to mitigate potential side effects associated with hormone deprivation. The compound is characterized by its specific molecular structure, which includes a steroid backbone modified to enhance its pharmacological properties. Safety and efficacy profiles have been established through clinical trials, and it is generally well-tolerated, although some patients may experience side effects such as hypertension, hypokalemia, and liver function abnormalities. As with any medication, it is essential to use abiraterone mesylate under the guidance of a healthcare professional.

CAS 1382475-35-5

Abiraterone mesylate

Abiraterone Acetate P-Toluene Sulfonyl Ester

Ref: ST-EA-CP-A67023